KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Csx (CSX) EBT (2016 - 2025)

Csx (CSX) has disclosed EBT for 17 consecutive years, with $951.0 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 1.6% to $951.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 billion, a 16.58% decrease, with the full-year FY2025 number at $3.8 billion, down 16.58% from a year prior.
  • EBT was $951.0 million for Q4 2025 at Csx, up from $898.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.6 billion in Q2 2022 to a low of $858.0 million in Q1 2025.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: surged 134.66% in 2021, then fell 26.54% in 2025.
  • Csx's EBT stood at $1.3 billion in 2021, then fell by 5.1% to $1.2 billion in 2022, then decreased by 3.87% to $1.1 billion in 2023, then dropped by 18.18% to $936.0 million in 2024, then increased by 1.6% to $951.0 million in 2025.
  • Per Business Quant, the three most recent readings for CSX's EBT are $951.0 million (Q4 2025), $898.0 million (Q3 2025), and $1.1 billion (Q2 2025).